Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 14, 2011
Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALKDaniela Di Paolo, Chiara Brignole, Fabio Pastorino, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2011
Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastomaDaniela Di Paolo, Chiara Ambrogio, Fabio Pastorino, et al.Cancer Research|September 7, 2014
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasisCinzia Martinengo, Teresa Poggio, Matteo Menotti, et al.Plos One|October 20, 2010
PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastomaTiziana Bachetti, Daniela Di Paolo, Simona Di Lascio, et al.Molecular Oncology|June 9, 2021
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signallingDaniela Di Paolo, Francesca Pontis, Massimo Moro, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 3, 2015
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastomaGuendalina Zuccari, Andrea Milelli, Fabio Pastorino, et al.Cancers|February 11, 2023
Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric OncologyFabio Pastorino, Mario Capasso, Chiara Brignole, et al.Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsDaniela Di Paolo, Fabio Pastorino, Chiara Brignole, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin AMüjdat Zeybel, Saimir Luli, Laura Sabater, et al.Ebiomedicine|October 9, 2022
Nucleolin expression has prognostic value in neuroblastoma patientsDavide Cangelosi, Chiara Brignole, Veronica Bensa, et al.Pageof 5